Acta Haematologica最新文献

筛选
英文 中文
Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide. 共识声明强调全球统一慢性淋巴细胞白血病管理的必要性。
IF 1.7 4区 医学
Acta Haematologica Pub Date : 2024-01-01 Epub Date: 2023-08-07 DOI: 10.1159/000533349
Stefano Molica, Marco Rossi, David Allsup
{"title":"Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide.","authors":"Stefano Molica, Marco Rossi, David Allsup","doi":"10.1159/000533349","DOIUrl":"10.1159/000533349","url":null,"abstract":"<p><p>In addition to the European Society for Medical Oncology (ESMO) and National Comprehensive Cancer Network (NCCN) guidelines that are reference standards for the treatment of chronic lymphocytic leukemia (CLL) in Europe and the USA, several consensus statements, formulated by independent, multidisciplinary panels of specialists, have been developed to provide region-specific guidance for the management of CLL.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"257-259"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9944849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies. 急性髓性白血病的免疫疗法:当前趋势、挑战和策略》。
IF 1.7 4区 医学
Acta Haematologica Pub Date : 2024-01-01 Epub Date: 2023-09-06 DOI: 10.1159/000533990
Evan C Chen, Jacqueline S Garcia
{"title":"Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies.","authors":"Evan C Chen, Jacqueline S Garcia","doi":"10.1159/000533990","DOIUrl":"10.1159/000533990","url":null,"abstract":"<p><strong>Background: </strong>In the past decade, there have been significant breakthroughs in immunotherapies for B-cell lymphoid malignancies and multiple myeloma, but progress has been much less for acute myeloid leukemia (AML). Nevertheless, challenge begets innovation and several therapeutic strategies are under investigation.</p><p><strong>Summary: </strong>In this review, we review the state of the art in AML immunotherapy including CD33- and CD123-targeted agents, immune checkpoint inhibition, and adoptive cell therapy strategies. We also share conceptual frameworks for approaching the growing catalog of investigational AML immunotherapies and propose future directions for the field.</p><p><strong>Key messages: </strong>Immunotherapies for AML face significant challenges but novel strategies are in development.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"198-218"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10226340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune Dysfunction and Infection - Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs. 免疫功能失调与感染--CLL 与治疗之间的相互作用:对当前治疗范例和未满足需求的反思。
IF 1.7 4区 医学
Acta Haematologica Pub Date : 2024-01-01 Epub Date: 2023-07-27 DOI: 10.1159/000533234
Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, Carsten Utoft Niemann
{"title":"Immune Dysfunction and Infection - Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs.","authors":"Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, Carsten Utoft Niemann","doi":"10.1159/000533234","DOIUrl":"10.1159/000533234","url":null,"abstract":"<p><strong>Background: </strong>Chronic lymphocytic leukemia (CLL) is a hematological malignancy characterized by immune dysfunction, which significantly contributes to increased morbidity and mortality due to infections.</p><p><strong>Summary: </strong>Advancement in therapeutic strategies based on combination chemoimmunotherapy and targeted treatment have increased life expectancy for patients affected by CLL. However, mortality and morbidity due to infection showed no improvement over the last decades. Although therapy options are highly efficient in targeting leukemic cells, several studies highlighted the interactions of different treatments with the tumor microenvironment immune components, significantly impacting their clinical efficacy and fostering increased risk of infections.</p><p><strong>Key messages: </strong>Given the profound immune dysfunction caused by CLL itself, treatment can thus represent a double-edged sword. Thus, it is essential to increase our understanding and awareness on how conventional therapies affect the disease-microenvironment-infection axis to ensure the best personalized strategy for each patient. This requires careful consideration of the advantages and disadvantages of efficient treatments, whether chemoimmunotherapy or targeted combinations, leading to risk of infectious complications. To this regard, our machine learning-based algorithm CLL Treatment-Infection Model, currently implemented into the local electronic health record system for Eastern Denmark, aims at early identification of patients at high risk of serious infections (PreVent-ACaLL; NCT03868722). We here review strategies for management of immune dysfunction and infections in CLL.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"84-98"},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9876819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Challenging Management of Acute Thrombotic Microangiopathy in Pregnancy. 妊娠期急性血栓性微血管病的挑战性管理。
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 DOI: 10.1159/000527553
Bárbara Marques, Catarina Nora, Daniela Coelho, Patrícia Martinho, Teresa Fidalgo, Marília Gomes, Letícia Ribeiro, Catarina Geraldes, José Pedro Carda
{"title":"The Challenging Management of Acute Thrombotic Microangiopathy in Pregnancy.","authors":"Bárbara Marques,&nbsp;Catarina Nora,&nbsp;Daniela Coelho,&nbsp;Patrícia Martinho,&nbsp;Teresa Fidalgo,&nbsp;Marília Gomes,&nbsp;Letícia Ribeiro,&nbsp;Catarina Geraldes,&nbsp;José Pedro Carda","doi":"10.1159/000527553","DOIUrl":"https://doi.org/10.1159/000527553","url":null,"abstract":"<p><p>Thrombotic microangiopathy is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ injury. Pregnancy-associated thrombotic microangiopathy is a severe disorder with a high risk of maternal mortality and poor fetal outcomes. Preeclampsia/eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome are the most common causes, and hemolytic uremic syndrome or thrombotic thrombocytopenic purpura are rare causes. Due to overlapping clinical findings, the differential diagnosis is challenging and should be managed by a multidisciplinary team. We present a case of a 38-year-old woman at 40 weeks of second gestation, admitted with thrombotic microangiopathy being the final diagnosis not immediately clear.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":"146 1","pages":"72-75"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9219791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia. CD20在费城染色体阴性B细胞前体急性淋巴细胞白血病患儿中表达的预后意义。
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 Epub Date: 2023-05-07 DOI: 10.1159/000530849
Yu Wang, Yu-Juan Xue, Yue-Ping Jia, Ying-Xi Zuo, Ai-Dong Lu, Le-Ping Zhang
{"title":"Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.","authors":"Yu Wang,&nbsp;Yu-Juan Xue,&nbsp;Yue-Ping Jia,&nbsp;Ying-Xi Zuo,&nbsp;Ai-Dong Lu,&nbsp;Le-Ping Zhang","doi":"10.1159/000530849","DOIUrl":"10.1159/000530849","url":null,"abstract":"<p><strong>Introduction: </strong>The prognostic significance of CD20 in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains unclear. Therefore, in this study, we evaluated the prognostic value of CD20 expression in leukemia blasts in pediatric BCP-ALL at our institute.</p><p><strong>Methods: </strong>Between 2005 and 2017, 796 children with newly diagnosed Philadelphia-negative BCP-ALL were enrolled consecutively; clinical characteristics and treatment outcomes were analyzed and compared between CD20-positive and CD20-negative groups.</p><p><strong>Results: </strong>CD20 positivity was observed in 22.7% of enrolled patients. The analysis of overall and event-free survival showed that white blood cell count ≥50 × 109/L, no ETV6-RUNX1, day 33 minimal residual disease (MRD) ≥0.1%, and week 12 MRD ≥0.01% were independent risk factors. Meanwhile, in the CD20-positive group, week 12 MRD ≥0.01% was the only factor associated with long-term survival. Moreover, subgroup analysis revealed that in patients with extramedullary involvement (p = 0.047), MRD ≥0.1% on day 33 (p = 0.032), or MRD ≥0.01% at week 12 (p = 0.004), CD20 expression led to a poorer outcome compared to those without CD20 expression.</p><p><strong>Conclusions: </strong>Pediatric BCP-ALL with CD20 expression had unique clinicopathological characteristics, and MRD remained the major prognostic factor. CD20 expression had no prognostic value in pediatric BCP-ALL.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"349-357"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9754731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia. 复发或难治性免疫性血小板减少症患者脾切除术预后的预测。
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 DOI: 10.1159/000530678
Philip Murphy
{"title":"Prediction of Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia.","authors":"Philip Murphy","doi":"10.1159/000530678","DOIUrl":"https://doi.org/10.1159/000530678","url":null,"abstract":"A recent publication by Kwag et al suggests that first line response to intravenous immunoglobulins in patients with immune thrombocytopenia (ITP) may predict long term response to splenectomy. Predominant platelet sequestration using platelet kinetic studies may similarly predict ITP patients who respond rest to splenectomy. A study comparing response to intravenous immunoglobulins and platelet kinetic studies prior to splenectomy for ITP might identify to identify the optimal means of predicting response to splenectomy.","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":"146 4","pages":"343-344"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9974972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Follicular Regulatory T Cells/Follicular Helper T Cells in Primary Immune Thrombocytopenia. 滤泡调节性T细胞/滤泡辅助性T细胞在原发性免疫性血小板减少症中的作用
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 DOI: 10.1159/000529963
Mingling Sun, Xiujuan Wang, Lei Wang, Xinyou Wang, Wenxia Fan, Ying Liu, Qinzhi Li, Ning Zhang, Xinhong Guo
{"title":"The Role of Follicular Regulatory T Cells/Follicular Helper T Cells in Primary Immune Thrombocytopenia.","authors":"Mingling Sun,&nbsp;Xiujuan Wang,&nbsp;Lei Wang,&nbsp;Xinyou Wang,&nbsp;Wenxia Fan,&nbsp;Ying Liu,&nbsp;Qinzhi Li,&nbsp;Ning Zhang,&nbsp;Xinhong Guo","doi":"10.1159/000529963","DOIUrl":"https://doi.org/10.1159/000529963","url":null,"abstract":"<p><strong>Introduction: </strong>Immune thrombocytopenia (ITP) is an autoimmune disease characterized by thrombocytopenia. Herein, we sought to identify potential immune-related therapeutic targets in ITP.</p><p><strong>Methods: </strong>The differentially expressed genes (DEGs) between ITP patients and controls in GSE43177 and PRJNA299534 were analyzed. The intersections of the two DEG groups were screened as common genes, and enrichment analysis was performed. Additionally, differential analysis of immune cell levels between ITP and controls was performed. Changes in the proportions of T follicular helper (Tfh) and follicular regulatory T (Tfr) cells in peripheral blood samples from ITP patients, ITP patients responding to therapy, and healthy controls were identified. The expression changes in B-cell lymphoma (Bcl)-6 and interleukin (IL)-21 were further evaluated.</p><p><strong>Results: </strong>A total of 76 common genes were identified, and enrichment analysis found that these genes were mainly associated with neutrophil-mediated immunity, the MAPK signaling pathway, and the FOXO signaling pathway. Furthermore, we found different levels of Tfh cells in patients with ITP and controls. The level of Tfh cells in the peripheral blood is significantly increased in ITP patients and declines after responding to therapy. The Tfr/Tfh ratio was reduced in ITP patients and increased after responding to therapy. IL-21 and Bcl-6 were more highly expressed in ITP patients than in controls.</p><p><strong>Conclusion: </strong>We identified abnormally expressed genes in ITP related to immune-related biological functions. We further identified the changes in Tfh and Tfr cells during ITP treatment. This provides a rationale for immunotherapy in ITP patients.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":"146 4","pages":"267-276"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9983998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar. Waldenström巨球蛋白血症和非IgM型淋巴母细胞淋巴瘤在基因上相似。
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 Epub Date: 2023-03-14 DOI: 10.1159/000530100
Maaya Awata-Shiraiwa, Akihiko Yokohama, Yukihiro Kanai, Nanami Gotoh, Tetsuhiro Kasamatsu, Hiroshi Handa, Takayuki Saitoh, Hirokazu Murakami, Junko Hirato, Hayato Ikota, Norifumi Tsukamoto
{"title":"Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar.","authors":"Maaya Awata-Shiraiwa,&nbsp;Akihiko Yokohama,&nbsp;Yukihiro Kanai,&nbsp;Nanami Gotoh,&nbsp;Tetsuhiro Kasamatsu,&nbsp;Hiroshi Handa,&nbsp;Takayuki Saitoh,&nbsp;Hirokazu Murakami,&nbsp;Junko Hirato,&nbsp;Hayato Ikota,&nbsp;Norifumi Tsukamoto","doi":"10.1159/000530100","DOIUrl":"10.1159/000530100","url":null,"abstract":"<p><strong>Introduction: </strong>Waldenström macroglobulinemia (WM) represents a subset of lymphoplasmacytic lymphoma (LPL) with the immunoglobulin (Ig)M paraprotein. MYD88 L265P and CXCR4 mutations are common mutations in WM patients, and mutations in ARID1A and KMT2D (MLL2) have also been reported. However, little information has been accumulated on genetic changes in LPL with other paraproteins like IgG.</p><p><strong>Methods: </strong>We therefore aimed to evaluate genetic differences between WM and LPL with non-IgM paraprotein (non-IgM-type LPL) using targeted next-generation sequencing (NGS) in 20 Japanese patients (10 with WM, 10 with non-IgM-type LPL).</p><p><strong>Results: </strong>Mutations were detected in ARID1A (10%), CXCR4 (20%), MYD88 (90%), and KMT2D (0%) for WM patients and in ARID1A (10%), CXCR4 (20%), MYD88 (70%), and KMT2D (10%) for non-IgM-type LPL patients. No significant differences were identified. No mutations were detected in NOTCH2, PRDM1, CD274 (PD-L1), PDCD1LG2 (PD-L2), RAG2, MYBBP1A, TP53, or CD79B.</p><p><strong>Discussion: </strong>Mutant allele frequency in MYD88 L265P did not differ significantly between WM and non-IgM-type LPL. Most mutations detected by NGS were subclonal following MYD88 L265P, although one non-IgM-type LPL patient harbored only CXCR4 S338X mutation. Our NGS analyses reveal genetic characteristics in LPL patients and suggest genetic similarities between these two subsets of LPL, WM and non-IgM-type.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"384-390"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9465826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient. NPM1突变的急性髓细胞白血病和播散性白血病:Venetoclax/阿扎胞苷联合治疗高龄患者实现分子完全缓解。
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 Epub Date: 2023-05-17 DOI: 10.1159/000531101
Pasquale Niscola, Carla Mazzone, Stefano Fratoni, Nicolina Rita Ardu, Laura Cesini, Marco Giovannini, Tiziana Ottone, Lucia Anemona, Maria Teresa Voso, Paolo de Fabritiis
{"title":"Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient.","authors":"Pasquale Niscola,&nbsp;Carla Mazzone,&nbsp;Stefano Fratoni,&nbsp;Nicolina Rita Ardu,&nbsp;Laura Cesini,&nbsp;Marco Giovannini,&nbsp;Tiziana Ottone,&nbsp;Lucia Anemona,&nbsp;Maria Teresa Voso,&nbsp;Paolo de Fabritiis","doi":"10.1159/000531101","DOIUrl":"10.1159/000531101","url":null,"abstract":"<p><p>We describe a case of acute myeloid leukemia with NPM1 mutation and disseminated leukemia cutis in a very old patient, who achieved a long-lasting response to the azacitidine/venetoclax combination with molecular complete remission, given the potential value of this rarely observed clinical outcome.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"408-412"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9522852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Longitudinal Assessment of the Natural Change in Haemoglobin, Haematocrit, and Mean Corpuscular Volume with Age. 血红蛋白、红细胞压积和平均红细胞体积随年龄自然变化的纵向评估。
IF 2.4 4区 医学
Acta Haematologica Pub Date : 2023-01-01 DOI: 10.1159/000529356
Idan Goldberg, Eytan Cohen, Anat Gafter-Gvili, Tzippy Shochat, Eitan Kugler, Ili Margalit, Elad Goldberg, Pia Raanani, Ilan Krause
{"title":"A Longitudinal Assessment of the Natural Change in Haemoglobin, Haematocrit, and Mean Corpuscular Volume with Age.","authors":"Idan Goldberg,&nbsp;Eytan Cohen,&nbsp;Anat Gafter-Gvili,&nbsp;Tzippy Shochat,&nbsp;Eitan Kugler,&nbsp;Ili Margalit,&nbsp;Elad Goldberg,&nbsp;Pia Raanani,&nbsp;Ilan Krause","doi":"10.1159/000529356","DOIUrl":"https://doi.org/10.1159/000529356","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to assess the natural annual trends in the levels of haemoglobin, haematocrit, and mean corpuscular volume (MCV) in a population of adults, together with the influence of different clinical parameters on these trends.</p><p><strong>Methods: </strong>A retrospective analysis was carried out on data from a large cohort of subjects attending a screening centre in Israel. For each subject, the yearly average change of haemoglobin, haematocrit, and MCV was calculated. Statistical analysis was performed for the whole cohort and for different subgroups.</p><p><strong>Results: </strong>The study included 3,551 subjects. The average annual rates of decline were found to be -0.0550 g/dL (95% confidence interval [CI] -0.0590 g/dL to -0.0503 g/dL) and -0.097% (95% CI -0.112% to -0.083%) for haemoglobin and haematocrit, respectively. An average annual increase in the MCV level by 0.184 fL (95% CI 0.168 fL-0.200 fL) was found. Among men, the rate of decline in haemoglobin was found to be twice as high compared with women -0.06 g/dL versus -0.03 g/dL, respectively (p = 0.0063). In a multivariate analysis, gender remained the only parameter significantly associated with the annual decline of haemoglobin (p = 0.0001).</p><p><strong>Conclusion: </strong>An annual average decrease in the levels of haemoglobin and haematocrit together with an annual increase in MCV was found. These changes were more prominent in men.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":"146 3","pages":"206-213"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9568688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信